Traduction en anglais : Determinants of treatment costs for unstable angina.
Unstable angina, a common serious clinical entity, is associated with a high rate of complications.
The aim of our study was to evaluate treatment costs of patients with uncomplicated and complicated follow-up in order to evaluate the economic consequences of new therapeutic strategies, like the introduction of GPIIb/Illa blockers at our hospital.
All 103 patients who were admitted to the medical intensive care unit of Johann Wolfgang Goethe-University Hospital, Frankfurt am Main between March 2,1992 and October 31,1997 for unstable angina of Braunwald class III B were enrolled in the study.
Clinical events were the occurrence of refractory ischemia, non transmural or transmural myocardial infarction or cardiac death.
The following were documented : duration of treatment in the ICU and in the general ward, cardiac catheterizations, balloon angioplasties (PTCA), and bypass operations.
Treatment costs were calculated on the basis of daily rates, flat rates, and special fees.
Following successful primary treatment, a clinical event occurred in 48 of the 103 patients, recurrent refractory ischemia in 34 patients, nontransmural infarction in eight patients, transmural infarction in three patients, and death in four patients.
Patients with events were significantly less likely to have had a history of PTCA (38vs 60p<0.05) and were significantly less likely to be undergoing long-term treatment with aspirin (63vs 80, p<0.05). (...)
Mots-clés Pascal : Angor instable, Homme, Coût, Economie santé, Exploration, Traitement, Déterminant, Hospitalisation, Evolution, Appareil circulatoire pathologie, Cardiopathie coronaire
Mots-clés Pascal anglais : Variant angina, Human, Costs, Health economy, Exploration, Treatment, Determinant, Hospitalization, Evolution, Cardiovascular disease, Coronary heart disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0279199
Code Inist : 002B12A03. Création : 16/11/1999.